Benedicto Crespo Facorro
Fundación para la Gestión de la Investigación en Salud de Sevilla · benedicto.crespo.sspa@juntadeandalucia.es · Andalusian Health Service
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
18
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers
0
PubMed author-name match
Trials
Studies that name Benedicto Crespo Facorro as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:31 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07153406 · Comparison of Esketamine Nasal Spray vs.Aripiprazole in Treat.Resistant Major Depressive Disorder in Elderly PatientsFundación Pública Andaluza para la gestión de la Investigación en Sevilla · not yet recruiting · Depressive Disorder · principal investigator
- N/ANCT05083377 · Clozapine Use Pattern in the Province of SevilleFundación Pública Andaluza para la gestión de la Investigación en Sevilla · completed · Schizophrenia and Related Disorders · principal investigator
- Ph2/Ph3NCT04895488 · Cognitive Effects of Adjuvant Vortioxetine in Early SchizophreniaFundación Pública Andaluza para la gestión de la Investigación en Sevilla · unknown · Cognitive Impairment With Primary Psychotic Disorder, Negative Symptoms With Primary Psychotic Disorder · principal investigator
- Ph2NCT04529226 · Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant PsychosisFundación Pública Andaluza para la gestión de la Investigación en Sevilla · unknown · Psychosis, Intellectual Disability · principal investigator
- Ph4NCT03883204 · Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-upFundación Marques de Valdecilla · unknown · Schizophrenia, Psychotic Disorders, Psychosis · principal investigator
- N/ANCT03090490 · 10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis IndividualsFundación Marques de Valdecilla · unknown · Schizophrenia, Schizophrenia Relapse, Schizophrenia Spectrum and Other Psychotic Disorders · principal investigator
- Ph4NCT03090503 · Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-upFundación Marques de Valdecilla · unknown · Schizophrenia, Psychotic Disorders, Psychosis · principal investigator
- N/ANCT02916303 · Cost-effectiveness of Interventions in First-episode PsychosisFundación Marques de Valdecilla · unknown · Schizophrenia · principal investigator
- N/ANCT02897167 · Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia PatientsFundación Marques de Valdecilla · completed · Schizophrenia, Mental Disorders, Psychotic Disorders · principal investigator
- N/ANCT02858102 · Impact of Aerobic Exercise on Metabolic Syndrome, Neurocognition and Empowerment in Individuals With Mental DisordersFundación Marques de Valdecilla · unknown · Metabolic Syndrome, Mental Disorders · principal investigator
- Ph4NCT02745132 · Cognitive Impairments in Chronic Hepatitis C Patients and Potential Reversibility With New Agents (CICHepC)Instituto de Investigación Marqués de Valdecilla · unknown · Hepatitis C · principal investigator
- Ph4NCT02534363 · Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-upFundación Marques de Valdecilla · completed · Schizophrenia, Psychotic Disorders · principal investigator
- Ph4NCT02532491 · Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-upFundación Marques de Valdecilla · unknown · Schizophrenia, Psychotic Disorders · principal investigator
- Ph4NCT02526030 · Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-upFundación Marques de Valdecilla · completed · Schizophrenia, Psychotic Disorders · principal investigator
- Ph4NCT02305823 · Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective PsychosisFundación Marques de Valdecilla · completed · Schizophrenia, Psychotic Disorders · principal investigator
- N/ANCT02220504 · 3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis IndividualsFundación Marques de Valdecilla · completed · Schizophrenia, Schizophrenia Relapse, Schizophrenia Spectrum and Other Psychotic Disorders · principal investigator
- N/ANCT02205437 · Novel Candidate Genes for Treatment Response to Antipsychotics in SchizophreniaFundación Marques de Valdecilla · unknown · Schizophrenia · principal investigator
- N/ANCT02200588 · Longitudinal Long-term Study (10 Years) of the Sample of First Episode of Non-affective Psychosis: PAFIPFundación Marques de Valdecilla · unknown · Schizophrenia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:31 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.